Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1995
03/29/1995EP0644939A1 Protein kinase c (iota)
03/29/1995EP0644938A1 PRODUCTION OF STREPTAVIDIN FROM $i(BACILLUS SUBTILIS)
03/29/1995EP0644937A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression
03/29/1995EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/29/1995EP0644935A1 DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS
03/29/1995EP0644933A1 Constitutive and inducible epidermal vector systems
03/29/1995EP0644932A1 Purified forms of dnase
03/29/1995EP0644931A1 Recombinant herpesvirus of turkeys and uses thereof
03/29/1995EP0644930A1 Monoclonal antibody against the extra-villous trophoblast
03/29/1995EP0644929A1 System and method for transplantation of cells
03/29/1995EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
03/29/1995EP0644899A1 Production of recombinant human lactoferrin
03/29/1995EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID
03/29/1995EP0644774A1 Improved production of reproductive hormones
03/29/1995EP0644765A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
03/29/1995EP0620847A4 Preparation of pure cultures of post-mitotic human neurons.
03/29/1995EP0599868A4 Polyphenol oxidase genes.
03/29/1995EP0563144B1 Diagnosis for porcine malignant hyperthermia
03/29/1995EP0460190B1 Method for detecting malignant diseases
03/29/1995EP0393045B1 Fv antibody fragment production
03/29/1995EP0374162B1 Balanced constitutive inducible transcription system
03/29/1995EP0332667B1 Vector for integration site independent gene expression in mammalian host cells
03/29/1995CN1100757A Novel plasmid for production of CRM protein and diphtheria toxin
03/28/1995US5401847 DNA complexes with dyes designed for energy transfer as fluorescent markers
03/28/1995US5401836 Polynucleotides with sequences for genetic engineering
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401721 Antiulcer agents and antisecretory agents
03/28/1995US5401658 Vectors and methods for making such vectors and for expressing cloned genes
03/28/1995US5401651 DNA encoding ENA-78, a neutrophil activating factor
03/28/1995US5401650 Cloning and expression of biologically active α-galactosidase A
03/28/1995US5401643 Method of preparing an active human neutrophil chemotactic factor polypeptide
03/28/1995US5401642 Vectors and methods for making such vectors and for expressing cloned genes
03/28/1995US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof
03/28/1995US5401632 Triple helix purification and sequencing
03/28/1995US5401631 Universal eubacteria nucleic acid probes and assay methods
03/28/1995US5401627 Warts, cancer
03/28/1995CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response
03/28/1995CA2012631C Process for the production of hetero-bispecific antibodies
03/28/1995CA1334944C Signal peptide, dna sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
03/28/1995CA1334943C Leader sequence for the production of recombinant proteins
03/28/1995CA1334942C Production of m-csf
03/28/1995CA1334941C Cloning and expression of a host-protective immunogens of ibdv
03/28/1995CA1334940C Production of glucose oxidase in recombinant systems
03/28/1995CA1334927C Method of screening for protein inhibitors and activators
03/25/1995CA2132772A1 Improvement of gas and alcohol production by yeast
03/25/1995CA2132668A1 Heparin binding site structural analogues of fibroblast growth factors
03/23/1995WO1995008115A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
03/23/1995WO1995008003A1 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
03/23/1995WO1995008001A1 Dna sequence which binds transcriptional regulatory proteins activated in response to various cytokines and uses thereof
03/23/1995WO1995007996A1 Synthesis of adipic acid from biomass-derived carbon sources
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007993A1 Regulation of senescence
03/23/1995WO1995007992A2 Cloned glutamic acid decarboxylase
03/23/1995WO1995007991A2 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis
03/23/1995WO1995007990A1 A novel g protein-coupled receptor kinase grk6
03/23/1995WO1995007989A2 A disease resistance gene from maize and its use for disease resistance, as a selectable marker and as a gene identification probe
03/23/1995WO1995007988A1 PURIFIED pH NEUTRAL RHIZOCTONIA LACCASES AND NUCLEIC ACIDS ENCODING SAME
03/23/1995WO1995007987A2 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995WO1995007986A1 Pharmaceutical compositions containing ecotin and homologs thereof
03/23/1995WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine
03/23/1995WO1995007984A1 Human receptor h4-1bb
03/23/1995WO1995007983A1 Human mu opioid receptor
03/23/1995WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995WO1995007981A1 Grb3-3 gene, variants and uses thereof
03/23/1995WO1995007979A1 Synthesis of catechol from biomass-derived carbon sources
03/23/1995WO1995007978A1 A secretion sequence for the production of a heterologous protein in yeast
03/23/1995WO1995007935A1 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE
03/23/1995WO1995007934A2 Il8 inhibitors
03/23/1995WO1995007933A1 Methods and composition for the modulation of host immune response to allergens
03/23/1995WO1995007932A1 Improvements in or relating to haemoglobin
03/23/1995WO1995007931A1 Acylated insulin
03/23/1995WO1995007924A1 Ribozyme-based compositions for the modification of cutaneous phenotypes associated with aging and other conditions of the skin and hair
03/23/1995WO1995007923A1 Multi-unit ribozyme inhibition of oncogene expression
03/23/1995WO1995007922A1 Drug binding protein
03/23/1995WO1995007918A2 Pyrimidine derivatives for labeled binding partners
03/23/1995WO1995007907A1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995WO1995007715A1 Cd8+ cell antiviral factor
03/23/1995WO1995007714A1 DNA SEQUENCE ENCODING HUMAN CYSTATHIONINE β-SYNTHASE
03/23/1995WO1995007706A1 The semaphorin gene family
03/23/1995WO1995005480A3 Compositions and methods for detecting target nucleic acid sequences utilizing flanking sequence enzyme molecules
03/23/1995WO1995005474A3 Glucoamylase promoter obtained from neurospora crassa and its use in the production of heterologous polypeptides
03/23/1995WO1995005467A3 Chitinase, dna coding therefor and plants containing same
03/23/1995WO1995005393A3 Lipopolysaccharide-binding and neutralizing peptides
03/23/1995WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
03/23/1995WO1995003333A3 Tryptase inhibitor
03/23/1995WO1994029469A3 Plasmids suitable for gene therapy
03/23/1995WO1994028897A3 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
03/23/1995DE4331670A1 Antisense oligonucleotides against HSV-1 and the preparation thereof
03/23/1995CA2172842A1 Regulation of senescence
03/23/1995CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995CA2171869A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995CA2171739A1 Human mu opioid receptor
03/23/1995CA2171610A1 Cdna encoding a novel human protein tyrosine phosphatase
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2171288A1 Purified ph neutral rhizoctonia laccases and nucleic acids encoding same
03/23/1995CA2170638A1 Improvements in or relating to haemoglobin
03/23/1995CA2170405A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
1 ... 3770 3771 3772 3773 3774 3775 3776 3777 3778 3779 3780 3781 3782 3783 3784 3785 3786 3787 3788 3789 3790 ... 4023